TY - JOUR
T1 - Natural history of functional tricuspid regurgitation : implications of quantitative doppler assessment
AU - Bartko, Philipp E.
AU - Arfsten, Henrike
AU - Frey, Maria K.
AU - Heitzinger, Gregor
AU - Pavo, Noemi
AU - Cho, Anna
AU - Neuhold, Stephanie
AU - Tan, Timothy C.
AU - Strunk, Guido
AU - Hengstenberg, Christian
AU - Hulsmann, Martin
AU - Goliasch, Georg
PY - 2019
Y1 - 2019
N2 - OBJECTIVES This study sought to define the relationship between functional tricuspid regurgitation (TR) and mortality in patients with heart failure with reduced ejection fraction (HFrEF); and to establish the prognostic value of quantitative measures of TR severity (i.e., effective regurgitant orifice area [EROA] and regurgitant volume). BACKGROUND The significance of TR in chronic heart failure is controversial. Earlier studies have shown an independent impact of TR on mortality, whereas more recent evidence suggests myocardial impairment to be the driving force of mortality rather than TR itself. Earlier studies have used qualitative measures of TR severity, hence the prognostic value of more quantitative measures of TR severity (i.e., EROA and regurgitant volumes) remains unclear. METHODS We enrolled 382 patients with HFrEF on guideline-directed medical therapy and assessed TR EROA and regurgitant volume by Doppler/2-dimensional echocardiography. All-cause mortality was defined as the primary study endpoint. RESULTS TR severity was associated with the HFrEF phenotype with more symptoms (p = 0.004), higher neurohumoral activation (p < 0.001), progressive right-ventricular dilatation(p < 0.001), and impaired function(p < 0.001). Cox regression showed a strong association between quantitative measures of TR with mortality(all p < 0.001). Quantitative metrics of TR severity were consistently associated with mortality with a hazard ratio of 1.009(95% confidence interval: 1.004 to 1.013; p < 0.001) per 0.01 cm(2) increase of the EROA and of 1.013 (95% confidence interval: 1.007 to 1.020; p < 0.001) per 1-ml increase in regurgitant volume. Results remained unchanged after bootstrap- or clinical confounder-based adjustment. A spline curve pattern illustrates the association with mortality with thresholds for the EROA >= 0.2 cm(2), and the regurgitant volume >= 20 ml with sustained excess mortality thereafter. CONCLUSIONS This large-scale outcome study demonstrates the prognostic value of quantitative Doppler-echocardiographic measures of TR severity in HFrEF. The thresholds for EROA and TR regurgitant volume associated with mortality in our study fall within current ranges defining nonsevere TR. This may potentially impact therapeutic decision making, particularly timing of intervention. (C) 2019 by the American College of Cardiology Foundation.
AB - OBJECTIVES This study sought to define the relationship between functional tricuspid regurgitation (TR) and mortality in patients with heart failure with reduced ejection fraction (HFrEF); and to establish the prognostic value of quantitative measures of TR severity (i.e., effective regurgitant orifice area [EROA] and regurgitant volume). BACKGROUND The significance of TR in chronic heart failure is controversial. Earlier studies have shown an independent impact of TR on mortality, whereas more recent evidence suggests myocardial impairment to be the driving force of mortality rather than TR itself. Earlier studies have used qualitative measures of TR severity, hence the prognostic value of more quantitative measures of TR severity (i.e., EROA and regurgitant volumes) remains unclear. METHODS We enrolled 382 patients with HFrEF on guideline-directed medical therapy and assessed TR EROA and regurgitant volume by Doppler/2-dimensional echocardiography. All-cause mortality was defined as the primary study endpoint. RESULTS TR severity was associated with the HFrEF phenotype with more symptoms (p = 0.004), higher neurohumoral activation (p < 0.001), progressive right-ventricular dilatation(p < 0.001), and impaired function(p < 0.001). Cox regression showed a strong association between quantitative measures of TR with mortality(all p < 0.001). Quantitative metrics of TR severity were consistently associated with mortality with a hazard ratio of 1.009(95% confidence interval: 1.004 to 1.013; p < 0.001) per 0.01 cm(2) increase of the EROA and of 1.013 (95% confidence interval: 1.007 to 1.020; p < 0.001) per 1-ml increase in regurgitant volume. Results remained unchanged after bootstrap- or clinical confounder-based adjustment. A spline curve pattern illustrates the association with mortality with thresholds for the EROA >= 0.2 cm(2), and the regurgitant volume >= 20 ml with sustained excess mortality thereafter. CONCLUSIONS This large-scale outcome study demonstrates the prognostic value of quantitative Doppler-echocardiographic measures of TR severity in HFrEF. The thresholds for EROA and TR regurgitant volume associated with mortality in our study fall within current ranges defining nonsevere TR. This may potentially impact therapeutic decision making, particularly timing of intervention. (C) 2019 by the American College of Cardiology Foundation.
UR - https://hdl.handle.net/1959.7/uws:63599
U2 - 10.1016/j.jcmg.2018.11.021
DO - 10.1016/j.jcmg.2018.11.021
M3 - Article
SN - 1876-7591
VL - 12
SP - 389
EP - 397
JO - JACC: Cardiovascular Imaging
JF - JACC: Cardiovascular Imaging
IS - 3
ER -